Detalhe da pesquisa
1.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587237
2.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Circulation
; 149(21): 1627-1638, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581389
3.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342789
4.
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus Conference.
J Card Fail
; 30(2): 391-398, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806488
5.
The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis.
Cardiovasc Diabetol
; 23(1): 72, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360604
6.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
; 44(31): 2982-2993, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210743
7.
Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.
Lancet
; 399(10333): 1391-1400, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381194
8.
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event.
J Card Fail
; 29(6): 922-930, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796671
9.
Are Post Hoc Analyses on Subgroups Sufficient to Support New Treatment Algorithms of Heart Failure? The Case of SGLT2 Inhibitors Associated with Sacubitril/Valsartan.
Cardiology
; 147(1): 23-25, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587618
10.
Reflecting on the advancements of HFrEF therapies over the last two decades and predicting what is yet to come.
Eur Heart J Suppl
; 24(Suppl L): L2-L9, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545229
11.
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines.
Eur Heart J Suppl
; 24(Suppl L): L20-L28, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545230
12.
Current status of perioperative temporary mechanical circulatory support during cardiac surgery.
J Card Surg
; 37(12): 4304-4315, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229948
13.
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.
J Card Fail
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663906
14.
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
Curr Opin Cardiol
; 36(5): 672-681, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173772
15.
Trends, management and outcomes of acute myocardial infarction in chronic liver disease.
Int J Clin Pract
; 75(4): e13841, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220158
16.
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.
Molecules
; 26(21)2021 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771008
17.
Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.
Molecules
; 26(16)2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34443591
18.
Hyperkalemia in heart failure.
Curr Opin Cardiol
; 35(2): 150-155, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833959
19.
The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathies.
Eur Heart J
; 45(7): 507-509, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240715
20.
Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent? 1.
Can J Physiol Pharmacol
; 97(6): 503-514, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576226